Gaudium IVF And Women Health IPO
GMP, Subscription, Price, Dates & Financial Details
Healthcare Services
Gaudium IVF & Women Health Limited is a pan-India fertility and women’s healthcare provider, incorporated in March 2015. The company delivers Assisted Reproductive Technology (ART) services through a scalable hub-and-spoke model, enabling operational efficiency and wider patient reach across…
Open Date
Fri, 20 Feb 2026
Close Date
Tue, 24 Feb 2026
Price Band
₹ 75 – 79
Lot Size
189
Issue Size
₹ 165.00 Cr
Minimum Investment
₹ 14,931 (189 Shares)
Grey Market Premium Analysis
Day Wise GMP→Unofficial premium quoted in the grey market, tracked daily against the price band cap.
Grey market trading is unregulated. GMP figures are indicative only and should not be the sole basis for investment decisions - treat as a sentiment indicator, not a guarantee.
IPO Details
Gaudium IVF And Women Health IPO has successfully completed its IPO process and is now listed on the NSE and BSE. According to the Red Herring Prospectus (RHP), the IPO was a book-built issue with a total issue size of ₹165.00 Crore, comprising a fresh issue of 1.14 Crore equity shares aggregating to ₹90.00 Crore and an offer for sale (OFS) of 94.94 Lakh equity shares aggregating to ₹75.00 Crore by the existing shareholders.
The Gaudium IVF And Women Health IPO remained open for subscription from February 20, 2026, to February 24, 2026. The basis of allotment was finalized on February 25, 2026, and the company's shares were listed on the NSE and BSE on February 27, 2026.
The company had fixed the price band at ₹75 to ₹79 per share, with a lot size of 189 shares. Retail investors were required to make a minimum investment of ₹14,931 (based on the upper price band) to apply for one lot.
Bigshare Services Pvt Ltd served as the registrar to the issue. Sarthi Capital Advisors Private Limited acted as the Book Running Lead Managers (BRLMs) to the issue.
With the successful completion of the IPO process, Gaudium IVF and Women Health Limited is now a publicly listed company on the NSE and BSE. Investors can track the company's share price, trading performance, financial results, and corporate announcements through the stock exchanges.
Gaudium IVF And Women Health IPO Timeline (Tentative)
- IPO Open Date
- Fri, 20 Feb 26
- IPO Close Date
- Tue, 24 Feb 26
- Basis of Allotment
- Wed, 25 Feb 26
- Initiation of Refunds
- Wed, 25 Feb 26
- Credit of Shares to Demat
- Thu, 26 Feb 26
- Listing Date
- Fri, 27 Feb 26 — NSE & BSE
Open Date
20 February 2026
Close Date
24 February 2026
Basis Of Allotment
25 February 2026
Listing Date
27 February 2026
IPO Subscription
Check Live Subscription →The Gaudium IVF And Women Health IPO has received bids for 10,63,50,489 shares against 1,46,20,340 shares offered, resulting in an overall subscription of 7.27x. the NII category is subscribed 14.05x, Retail Investors 7.6x, and QIBs 1.62x. Within the NII category, BNII is subscribed 12.71x, while SNII is subscribed 16.73x.
QIB
1.62x
NII
14.05x
BNII
12.71x
SNII
16.73x
RII
7.6x
Total
7.27x
IPO Reservations
The Retail Individual Investor (RII) category has the highest allocation with 73,10,170 shares, representing 50% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 41,77,240 shares (28.57%), while Non-Institutional Investors (NIIs) receive 31,32,930 shares (21.43%).
| Category | Shares Offered | Shares Offered % |
|---|---|---|
| Qualified Institutions | 4,177,240 | 28.57% |
| Non-Institutional | 3,132,930 | 21.43% |
| BNII | 2,088,620 | 14.29% |
| SNII | 1,044,310 | 7.14% |
| Retail Investors | 7,310,170 | 50% |
| Total | 14,620,340 | 100% |
Financials Details(₹ in Crores)
| Particular | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 106.62 | 88.51 | 51.01 | 36.63 |
| Revenue | 49.75 | 70.96 | 48.15 | 44.26 |
| Profit After Tax | 12.51 | 19.13 | 10.32 | 13.53 |
| Net Worth | 58.85 | 46.3 | 26.99 | 22.73 |
| Reserve & Surplus | 28.16 | 15.6 | 26 | 21.74 |
| Total Borrowings | 22.51 | 18.93 | 15.73 | 9.78 |
Financials Performance
Performance Indicators
EPS Pre
Earnings per share before the IPO.
P/E Pre
IPO Offer Price ÷ EPS Pre.
EPS Post
Expected earnings per share after the IPO..
P/E (Post Issue)
IPO Offer Price ÷ EPS Post.
Gaudium IVF and Women Health Limited KPI Information
| Particular | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| ROE % | 21.25 | 41.31 | 38.23 | 59.51 |
| ROCE % | 21.03 | 39.7 | 38.74 | 54.4 |
| Debt / Equity | 0.38 | 0.41 | 0.58 | 0.43 |
| RoNW % | 21.34 | 41.71 | 39.3 | 59.11 |
| Pat Margin % | 25.14 | 26.96 | 21.43 | 30.56 |
Peers Comparison
| Company | Face Value | PE Ratio | EPS Basic | EPS Diluted | RoNW | Net Assets |
|---|---|---|---|---|---|---|
| Gaudium IVF and Women Health Ltd | 5 | 0.00 | 3.12 | 3.12 | 41.71 | 7.54 |
| Progyny Inc. | 0.0001 | 41.56 | 50.52 | 50.52 | 12.90 | 394.20 |
| Inspire IVF Public Company Ltd | 0.05 | 11.43 | 0.17 | 0.17 | 3.97 | 4.34 |
About Gaudium IVF and Women Health Limited
Gaudium IVF & Women Health Limited is a pan-India fertility and women’s healthcare provider, incorporated in March 2015. The company delivers Assisted Reproductive Technology (ART) services through a scalable hub-and-spoke model, enabling operational efficiency and wider patient reach across India.
Gaudium IVF operates over 30 locations, including seven company-owned hub centres and 28 spoke centres developed through strategic alliances with leading infertility specialists. Its hubs are situated in key urban markets—two in Delhi (Janakpuri and Kailash Colony), and one each in Mumbai (Khar West), Ludhiana, Srinagar, Patna, and Bengaluru—ensuring strong geographic coverage and accessibility. The company also serves international patients from countries such as Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.
The company offers a comprehensive range of fertility treatments, including In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), Frozen Embryo Transfer (FET), ovulation induction, fertility preservation through cryopreservation, and advanced genetic screening such as Preimplantation Genetic Testing (PGT). In addition to reproductive medicine, Gaudium provides integrated gynecological and obstetric services, including treatment for PCOD/PCOS, endometriosis management, high-risk pregnancy care, male infertility treatments, and minimally invasive laparoscopic and hysteroscopic procedures.
A key differentiator of the company is its holistic and patient-centric approach. Beyond clinical treatment, Gaudium IVF integrates fertility wellness programs that include nutritional counseling and psychological support to enhance patient outcomes. As of March 31, 2025, the company had a workforce of 124 employees, including seven consultancy doctors.
Competitive Strengths
- Strong patient-centric care model
- Experienced and specialized medical team
- Advanced laboratory infrastructure, including next-generation INTEGRA Ti labs for ICSI
- Highly technical ultrasound-guided (USG) services
- Strategically located hubs in prime urban centres
- Asset-light and scalable hub-and-spoke operating model
Overall, Gaudium IVF & Women Health Limited combines clinical expertise, advanced reproductive technologies, and a scalable business structure to strengthen its position in India’s growing fertility care market.
Gaudium IVF And Women Health IPO Promoters
- Dr. Manika Khanna
- Dr. Peeyush Khanna
- Vishad Khanna
Promoters Holding
Holding Pre Issue
99.99%
Holding Post Issue
71.30%
Gaudium IVF And Women Health IPO Objective
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Funding capital expenditure towards establishment of New IVF Centers of our Company . : 50.00Cr
- Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company. : 20.00Cr
- General Corporate Purposes
Gaudium IVF and Women Health Limited Address / Contact Details
Gaudium IVF & Women Health Limited
B1/51,Janak Puri,B-1,
New Delhi, New Delhi, 110058
Email:compliance@gaudiumivfcentre.com
Telephone: 011- 4885 8585.
Website:http://www.gaudiumivfcentre.com/
IPO Snapshot
Gaudium IVF And Women Health IPO Lot Size
The Gaudium IVF And Women Health IPO has a lot size of 189 shares. Retail investors require a minimum investment of ₹14,931 by applying for 1 lot (189 shares). The maximum application allowed for the retail category is 13 lots (2,457 shares), requiring an investment of ₹1,94,103.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 189 | 14,931.00 |
| Retail (Max) | 13 | 2,457 | 194,103.00 |
| S-HNI (Min) | 14 | 2,646 | 209,034.00 |
| S-HNI (Max) | 66 | 12,474 | 985,446.00 |
| B-HNI (Min) | 67 | 12,663 | 1,000,377.00 |
Issue Reservation
- QIB — 28.57%
- NII — 21.43%
- RII — 50%
Book Running Lead Managers
- Sarthi Capital Advisors Private Limited
IPO Documents & Links
Explore More IPOs
Currently Open
Coming Up Next
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Gaudium IVF And Women Health IPO?
Gaudium IVF And Women Health IPO is a Book-building IPO with a total issue size of ₹165 crore. The Gaudium IVF And Women Health IPO price band is ₹75 to 79 per share. The Gaudium IVF And Women Health IPO subscription opens on Fri, Feb 20, 2026, and closes on Tue, Feb 24, 2026. The Gaudium IVF And Women Health IPO will be listed on the BSE,NSE. Bigshare Services Pvt Ltd is the registrar for the Gaudium IVF And Women Health IPO.
When will the Gaudium IVF And Women Health IPO open for subscription?
The Gaudium IVF And Women Health IPO opens on Fri, Feb 20, 2026 and closes on Tue, Feb 24, 2026
What is Gaudium IVF And Women Health IPO Price Band?
Gaudium IVF And Women Health IPO Price Band is ₹75 to 79 per share.
What is Gaudium IVF And Women Health IPO Lot Size?
Gaudium IVF And Women Health IPO lot size is 189 shares, Retail investors need a minimum investment of ₹14931 based on the upper price band
What is the minimum investment for Gaudium IVF And Women Health IPO?
The minimum investment for Gaudium IVF And Women Health IPO is ₹14931, based on one lot of 189 shares at the upper price band of ₹79 per share.
How to apply for Gaudium IVF And Women Health IPO?
Investors can apply for the Gaudium IVF And Women Health IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Tue, Feb 24, 2026. The application amount remains blocked until the Gaudium IVF And Women Health IPO allotment is finalized.
What is Gaudium IVF And Women Health IPO Issue Size?
Gaudium IVF And Women Health IPO issue size is ₹165 crores.
What is the Gaudium IVF And Women Health IPO Allotment Date?
Gaudium IVF And Women Health IPO allotment date is Wed, Feb 25, 2026.
Who is the Gaudium IVF And Women Health IPO Registrar?
The registrar for Gaudium IVF And Women Health IPO is Bigshare Services Pvt Ltd. Investors can go to Bigshare Services Pvt Ltd website to check Gaudium IVF And Women Health IPO allotment status, refund processing, and other IPO-related information.
What is the Gaudium IVF And Women Health IPO GMP?
The Gaudium IVF And Women Health IPO GMP (Grey Market Premium) is ₹0 as of Fri, Feb 27, 2026. Based on the upper price band of ₹79 per share, the estimated Gaudium IVF And Women Health IPO listing price is ₹79, indicating a potential listing gain of approximately 0.00% over the issue price.
Who is the Gaudium IVF And Women Health IPO Lead Manager?
The book-running lead managers (BRLMs) for the Gaudium IVF And Women Health IPO are Sarthi Capital Advisors Private Limited. The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Gaudium IVF And Women Health IPO Red Herring Prospectus (RHP).